PERCEPTIVE ADVISORS LLC - Significant Ownership

Signature - Title
Joseph Edelman - Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by PERCEPTIVE ADVISORS LLC.

Significant Ownership of PERCEPTIVE ADVISORS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADGM Adagio Medical Holdings, Inc. Common Stock, $0.0001 par value per share 73.6% $17.2M 15.3M Perceptive Advisors LLC Dec 31, 2024
TRIB Trinity Biotech plc Class A Ordinary Shares, $0.0109 par value per share 19.8% $60.1M 85.8M 0% Perceptive Advisors LLC Mar 21, 2025
SLDB Solid Biosciences Inc. Common Stock, $0.001 par value per share 15.6% $67M 11.9M Perceptive Advisors LLC Feb 19, 2025
NAUT Nautilus Biotechnology, Inc. Common Stock, par value $0.0001 per share 10% $21M 12.6M Perceptive Advisors LLC Jan 31, 2025
IRD Opus Genetics, Inc. Common Stock, $0.0001 par value per share 9.99% $4.19M 4.51M Perceptive Advisors LLC Mar 24, 2025
TRAW Traws Pharma, Inc. Common Stock, par value $0.01 per share 9.9% $1.09M 387K Perceptive Advisors LLC Dec 31, 2024
PRAX Praxis Precision Medicines, Inc Common Stock, par value $0.0001 per share 9.5% $70.6M 1.83M Perceptive Advisors LLC Dec 31, 2024
OM Outset Medical, Inc. Common Stock, $0.001 par value per share 9.5% $3.09M 5.63M Perceptive Advisors LLC Jan 8, 2025
ALDX ALDEYRA THERAPEUTICS, INC. Common Stock, par value $0.001 per share 8.2% $33.2M 4.88M Perceptive Advisors LLC Apr 3, 2025
FOLD Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share 8.1% $215M 24.2M Perceptive Advisors LLC Dec 31, 2024
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 7.9% $23.6M 6.77M Perceptive Advisors LLC Dec 31, 2024
IOVA Iovance Biotherapeutics, Inc. Common Stock, par value $0.000041666 per share 7.3% $77.8M 22.1M Perceptive Advisors LLC Dec 31, 2024
AVR Anteris Technologies Global Corp. Common Stock, par value $0.0001 per share 6.7% $16.7M 2.44M Perceptive Advisors LLC Dec 31, 2024
CELC Celcuity Inc. Common Stock, $0.001 par value per share 6.4% $23.7M 2.36M Perceptive Advisors LLC Dec 31, 2024
IVA Inventiva S.A. Ordinary shares, nominal value Euro 0.01 per share 5.8% $16.7M 5.56M Perceptive Advisors LLC Dec 13, 2024
CTNM Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share 5.6% $10.7M 1.44M Perceptive Advisors LLC Dec 31, 2024
EWTX Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.5% $145M 5.16M Perceptive Advisors LLC Feb 13, 2025
ENSC Ensysce Biosciences, Inc. Common Stock, par value $0.0001 per share 5.3% $338K 86.7K 0% Perceptive Advisors LLC Mar 31, 2025
VRCA Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share 5.1% $2.79M 4.73M Perceptive Advisors LLC Dec 31, 2024
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 5.1% $1.99M 167K Perceptive Advisors LLC Dec 31, 2024
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.5% $7.35M 5.88M Perceptive Advisors LLC Dec 31, 2024
BDSX Biodesix, Inc. Common Stock, par value $0.001 per share 4.5% $5.74M 6.67M Perceptive Advisors LLC Dec 31, 2024
SYRE Spyre Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.4% $47.8M -$186M 2.57M -79.6% Perceptive Advisors LLC Dec 31, 2024
FBRX Forte Biosciences, Inc. Common Stock, par value $0.001 per share 2.5% $984K 164K Perceptive Advisors LLC Dec 31, 2024
APLT Applied Therapeutics, Inc. Common Stock, $0.0001 par value per share 2.4% $1.43M 2.86M Perceptive Advisors LLC Dec 31, 2024

Schedules 13D/G Reported by PERCEPTIVE ADVISORS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.